Properties
Description
NU 6102 is an CDK kinase inhibitor that disrupts cell division processes. It targets Cdk1/cyclin B, CDK2/cyclin A3, CDK4, and DYRK1A.
Molecular Formula
C18H22N6O3S
Targets
Cdk1/cyclin B: 9.5 nM; CDK2/cyclin A3: 5.4 nM; CDK4: 1.6 μM; DYRK1A: 0.9 μM
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
NU 6102 can be used to investigate the selective inhibition of CDK2 and its implications in cancer therapy.
